Coronavirus (COVID-19) Visitor Policy & Advisory: Adventist HealthCare is taking appropriate steps to protect the safety of our patients, caregivers and community. Learn More
Emergency Room Wait Times
Home > Clinical Trials > Clinical Trial Search Results
Connect® MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
A Phase I/II study to determine the maximum tolerated dose and to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of antroquinonol in combination with nab-paclitaxel and gemcitabine in first line metastatic pancreatic cancer.
In this study, participants with multiple types of advanced solid tumors that have progressed on standard of care therapy will be treated with pembrolizumab.
Study to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia or myelofibrosis.
This is a randomized study to assess the efficacy and safety of the study drug ublituximab and TGR-1202 with or without Bendamustine and then TGR-1202 alone in patients with previously treated Non-Hodgkin’s Lymphoma.
A Study of MGCD516 in Patients With Advanced Cancer and Any Loss of function mutation in CBL Genetic Alteration in AXL
Effect of Tumor Treating Fields (TTFields, 150 kHz)in Combination With Gemcitabine and Nab-paclitaxel to Treat Locally-advanced Pancreatic Adenocarcinoma Concomitant.
Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.
Set Your Location
Setting your location helps us to show you nearby providers and locations based on your healthcare needs.